The blood test measures p-tau217, which indicates the presence of amyloid and tau proteins - hallmarks of Alzheimer’s disease - in the brain.
A major UCL-led clinical trial, aiming to transform the diagnosis of Alzheimer's disease through a simple blood test, is now welcoming its first participants who will be recruited via memory clinics ...